Point/counterpoint: Should full agonist opioid medications be offered to hospitalized patients for management of opioid withdrawal?

Sam J Stern^{1

2}, Joseph L D'Orazio^{3

4}, Brian D Work^{1

5}, Susan L Calcaterra⁶, Ashish P Thakrar^{7

8}

Affiliations

¹ Division of Hospital Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
² Lewis Katz School of Medicine, Center for Urban Bioethics, Philadelphia, Pennsylvania, USA.
³ Cooper Center for Healing, Camden, New Jersey, USA.
⁴ Department of Emergency Medicine, Division of Toxicology and Addiction Medicine, Cooper Medical School of Rowan University, Camden, New Jersey, USA.
⁵ Prevention Point Philadelphia, Philadelphia, Pennsylvania, USA.
⁶ Division of General Internal Medicine and Hospital Medicine, University of Colorado, Aurora, Colorado, USA.
⁷ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁸ Perelman School of Medicine, Center for Addiction Medicine and Policy, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Sam J Stern et al. J Hosp Med. 2024 Apr.

. 2024 Apr;19(4):339-343.

doi: 10.1002/jhm.13238. Epub 2023 Nov 29.

Sam J Stern^{1

2}, Joseph L D'Orazio^{3

4}, Brian D Work^{1

5}, Susan L Calcaterra⁶, Ashish P Thakrar^{7

8}

¹ Division of Hospital Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
² Lewis Katz School of Medicine, Center for Urban Bioethics, Philadelphia, Pennsylvania, USA.
³ Cooper Center for Healing, Camden, New Jersey, USA.
⁴ Department of Emergency Medicine, Division of Toxicology and Addiction Medicine, Cooper Medical School of Rowan University, Camden, New Jersey, USA.
⁵ Prevention Point Philadelphia, Philadelphia, Pennsylvania, USA.
⁶ Division of General Internal Medicine and Hospital Medicine, University of Colorado, Aurora, Colorado, USA.
⁷ Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
⁸ Perelman School of Medicine, Center for Addiction Medicine and Policy, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

No abstract available

Conflict of interest statement

CONFLICT OF INTEREST STATEMENT

The authors declare no conflict of interest.

1. Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional Drug Overdose Death Counts. National Center for Health Statistics; 2023. Accessed 28, January, 2023. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
1. Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002–12. Health Aff. 2016;35(5):832–837. doi: 10.1377/hlthaff.2015.1424 - DOI - PMC - PubMed
1. Alrawashdeh M, Klompas M, Kimmel S, et al. Epidemiology, outcomes, and trends of patients with sepsis and opioid-related hospitalizations in U.S. hospitals. Crit Care Med. 2021;49(12): 2102–2111. doi: 10.1097/ccm.0000000000005141 - DOI - PMC - PubMed
1. Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study. Subst Abus. 2020;41(4):519–525. doi: 10.1080/08897077.2019.1671942 - DOI - PubMed
1. Weinstein Z, Englander H. Reachable moment: hospital-based interventions. In: Wakeman SE, Rich JD, eds. Treating Opioid Use Disorder in General Medical Settings. Springer; Cham; 2021;43–56. doi: 10.1007/978-3-030-80818-1 - DOI